IRIS
DI NISIO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.226
EU - Europa 3.494
AS - Asia 2.500
SA - Sud America 174
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 11.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.190
SG - Singapore 1.083
CN - Cina 807
IE - Irlanda 769
UA - Ucraina 615
SE - Svezia 524
IT - Italia 446
TR - Turchia 408
GB - Regno Unito 266
DE - Germania 242
FR - Francia 180
FI - Finlandia 167
BR - Brasile 159
RU - Federazione Russa 144
IN - India 64
AT - Austria 37
VN - Vietnam 31
HK - Hong Kong 26
BE - Belgio 25
CA - Canada 25
TW - Taiwan 23
NL - Olanda 22
ES - Italia 15
CZ - Repubblica Ceca 13
EU - Europa 12
AU - Australia 10
JP - Giappone 8
IR - Iran 7
IL - Israele 6
KR - Corea 6
MX - Messico 6
TH - Thailandia 6
AR - Argentina 5
ID - Indonesia 5
MA - Marocco 5
RO - Romania 5
KE - Kenya 4
DZ - Algeria 3
EC - Ecuador 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
NO - Norvegia 3
PL - Polonia 3
BD - Bangladesh 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GR - Grecia 2
HU - Ungheria 2
IQ - Iraq 2
JM - Giamaica 2
LT - Lituania 2
MY - Malesia 2
SR - Suriname 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
Totale 11.439
Salva come PNG Salva come JPEG
Città #
Chandler 1.002
Jacksonville 861
Dublin 758
Singapore 669
Princeton 393
Izmir 270
Ashburn 227
Nanjing 214
Altamura 184
Southend 177
Wilmington 168
Santa Clara 142
Cambridge 137
Dearborn 132
Beijing 126
The Dalles 118
Boardman 90
Ann Arbor 83
Nanchang 71
Woodbridge 68
Helsinki 62
Chieti 61
Los Angeles 61
Houston 58
Hebei 46
Kunming 46
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 34
Seattle 32
Dong Ket 31
Nuremberg 26
Pescara 26
Vienna 26
Changsha 25
Hong Kong 24
Brussels 23
New York 22
Norwalk 22
Guangzhou 17
Hangzhou 17
São Paulo 16
Fairfield 14
Falls Church 13
Leawood 13
Munich 13
Pune 13
Taipei 12
Grevenbroich 11
Olomouc 11
Hefei 10
San Mateo 10
Edinburgh 9
Shanghai 9
Changchun 8
Jinan 8
Madrid 8
Rome 8
Romola 8
Sydney 8
Ardabil 7
Hanover 7
Moscow 7
Orange 7
Amsterdam 6
Augusta 6
Bangkok 6
London 6
Milan 6
Montreal 6
Mountain View 6
Stockholm 6
Suresnes 6
Teramo 6
Cheyenne 5
Frankfurt am Main 5
Mumbai 5
Redwood City 5
Rochester 5
Saint Louis 5
Tokyo 5
Toronto 5
Zhengzhou 5
Auburn Hills 4
Clifton 4
Des Moines 4
Florence 4
Istanbul 4
Lanzhou 4
Lappeenranta 4
Monmouth Junction 4
Nairobi 4
New Taipei 4
Ningbo 4
Paris 4
Pittsburgh 4
Plymouth 4
San Antonio 4
Seveso 4
Totale 7.056
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 207
Supportive management strategies for disseminated intravascular coagulation: An international consensus 134
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 122
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 116
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 106
Treatment of Lower Extremity Superficial Thrombophlebitis 102
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 92
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 90
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 89
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 88
Circulating leptin is associated with oxidized LDL in postmenopausal women. 87
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 87
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 86
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 85
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 85
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 84
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 83
The hematocrit and platelet target in polycytemia vera 82
Antithrombotic therapy and cancer 82
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 82
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 82
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 82
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 81
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 80
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 79
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 79
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 79
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 79
Non-O blood group and outcomes of in vitro fertilization 79
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 78
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 77
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 77
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 77
Effects of body composition on the procoagulant imbalance in obese patients 76
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 75
Rivaroxaban for cancer-associated cardiac thrombosis 75
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 75
Improving the diagnostic management of upper extremity deep vein thrombosis 74
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 74
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 73
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 73
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 72
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 72
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 72
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 72
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 71
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 71
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 71
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 71
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 70
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 70
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 70
D-Dimer test in cancer patients with suspected acute pulmonary embolism 70
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 70
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 69
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 69
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 68
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 68
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and symptomatic pulmonary embolism: a systematic review 67
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 67
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 67
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 67
Edoxaban for the treatment of cancer-associated venous thromboembolism 67
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 67
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 67
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 66
The SISET incorrectly cited the JAAM DIC scoring system 66
Decision analysis for cancer screening in idiopathic venous thromboembolism 66
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 66
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 65
Cannabinoids for medical use: A systematic review and meta-analysis 65
Deep vein thrombosis and pulmonary embolism 65
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 65
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 65
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 65
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 65
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 64
Treatment for superficial infusion thrombophlebitis of the upper extremity. 64
Pravastatin-dependent TGF-β1 effect on scavenger receptor class A expression in THP-1 human macrophages 64
Cell-derived microvesicles and cancer 63
Plasma cytokines and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular-weight heparin administration 63
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. 63
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: A systematic review 63
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 63
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 63
Cancer-associated unsuspected pulmonary embolism 63
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 63
Splanchnic vein thrombosis: Current perspectives 63
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 63
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: Guidance from the SSC of the ISTH 63
Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 62
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis 62
Inhaled analgesia for pain management in labour 62
Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? 61
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 61
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 61
Proximal and isolated distal deep vein thrombosis and Wells score accuracy in hospitalized patients 61
Low molecular-weight heparins improve the survival of cancer patients? 60
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 59
Clinical implications of incidental venous thromboembolism in cancer patients 59
Totale 7.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 0 0 0 0 0 0 0 0 0 192 22
2020/2021980 127 20 278 27 72 228 10 9 12 68 50 79
2021/2022758 10 10 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20252.405 200 619 402 63 52 98 76 250 345 130 170 0
Totale 12.144